Global Single Cell Genomics And Proteomics Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 3.50 Billion |
 Market Size (Forecast Year) |
USD 11.08 Billion |
 CAGR |
% |
| Major Markets Players |
Global Single Cell Genomics and Proteomics Market, By Single Cell Genomics Process Step (Cell isolation, Sample Preparation, Genomics Analysis), Single Cell Genomics Analytical Technology (Tubing PCR, qPCR, Microarray, Next-Generation-Sequencing, Other), Proteomics Components (Instruments, Reagents, Services), Proteomics Reagents (Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents), Proteomics Services & Software (Core Proteomics Services, Bioinformatics Software & Services), Single Cell Genomics Applications (Genomic Variation, Subpopulation Characterization, Circulating Tumor Cells, Cell Differentiation / Reprogramming Method, Others), Proteomic Application (Drug Discovery, Disease Diagnosis, Other), End- Users (Academic Institutes, Biopharmaceutical Companies, Clinical Research Institutes) – Industry Trends and Forecast to 2030.
Single Cell Genomics and Proteomics Market Analysis and Size
Increasing pharmaceutical and biotechnology R&D expenses and government funding for proteomics is essential to boosting market growth. There is a rising need for SCA(Single-cell Analysis) in proteomics, genomics, transcriptomics, and metabolomics. The increasing demand for analytical tools for innovative research and funding has led to the wide introduction of high-throughput equipment.
Data Bridge Market Research analyses that the single cell genomics and proteomics market, which was USD 3.5 billion in 2022, would rise to USD 11.08 billion by 2030 and is expected to undergo a CAGR of 15.50% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Single Cell Genomics and Proteomics Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Single Cell Genomics Process Step (Cell isolation, Sample Preparation, Genomics Analysis), Single Cell Genomics Analytical Technology (Tubing PCR, qPCR, Microarray, Next-Generation-Sequencing, Other), Proteomics Components (Instruments, Reagents, Services), Proteomics Reagents (Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents), Proteomics Services & Software (Core Proteomics Services, Bioinformatics Software & Services), Single Cell Genomics Applications (Genomic Variation, Subpopulation Characterization, Circulating Tumor Cells, Cell Differentiation / Reprograming Method, Others), Proteomic Application (Drug Discovery, Disease Diagnosis, Other), End- Users (Academic Institutes, Biopharmaceutical Companies, Clinical Research Institutes) |
|
Countries Covered |
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Thermo Fisher Scientific (U.S.), QIAGEN (Netherlands), Agilent Technologies, Inc. (U.S.), McKesson Corporation (U.S), R1 RCM Inc., (U.S), Allscripts Healthcare, LLC, (U.S), Accenture, (Ireland), Cognizant, (U.S), Siemens, (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), and BGI (China), B.D. (U.S.), Danaher (U.S.), Bruker (U.S.), 10x Genomics (U.S.), Luminex Corporation. (U.S.), Promega Corporation (U.S.) |
|
Market Opportunities |
|
Market Definition
Single-cell genomics is a method for examining the heterogeneity of cells and identifying new molecular characteristics concerning the clinical results. This strategy assists in allowing the complexity of cell variety to be identified in a sample without the loss of data that occurs when analyzing multicellular or bulk tissue samples.
Global Single Cell Genomics and Proteomics Market Dynamics
Drivers
- Increasing Funding for Market Development
There are numerous companies that are receiving funding for their market enhancement. For instance, Deepcell Inc., a U.S.-based company, received funding of USD 73 million to enhance its AI-powered single-cell analysis platform and move towards commercialization in 2022. Thus, major market players are considering investing in developing solutions to create revenue generation in the upcoming years. This factor leads to the growth of the market.
- Increasing Prevalence of Cancer
According to the American Cancer Society, cancer is the second most common cause of death in the U.S. As per the cancer statistics, in 2022, around 1.9 million new cancer cases are anticipated to occur in the U.S. This increasing incidence of cancer demands more and more studies and experiments, which further demands the use of SCA genomics and proteomics. Thus, this factor boosts market growth.
Opportunities
- Increasing Technological Advancements by Market Players
Several technologies, such as the development of next-generation sequencing for analyzing cellular expressions, mass spectrometry, and FISH (Fluorescence in situ hybridization), are greatly helping in the process of SCA. Furthermore, the market is witnessing the growing automation of machines and artificial intelligence for data analysis. Numerous software and computational methods have been developed and used because of their benefits, such as flexibility, scalability, and high success rates. For instance, there were more than 1000 single-cell RNA analysis tools in 2021. Thus, this factor boosts market growth.
- Increased Partnerships between Organizations and Market Players
There have been increasing partnerships between several organizations and market players, leading to the market's growth. For instance, Lifebit announced its partnership with Boehringer Ingelheim in 2022. The partnership will use the Cloud O.S. of Lifebit, the first federated platform for genomics, to build a data analytics infrastructure for Boehringer. Boehringer was also related to Lifebit's REAL platform in 2021 to increase the detection and tracking of disease outbreaks. Thus, this factor boosts market growth.
Restraints/Challenges
- High Cost of Proteomic Instruments
The high cost of proteomics instruments leads to market hindrances as they cannot be appointed by many underdeveloped nations' hospitals and research institutes. Also, a lot of maintenance is required to keep the consistency good. Thus, this factor impedes market growth.
This single cell genomics and proteomics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the single cell genomics and proteomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2021, the HIVETM scRNAseq Solution for single-cell isolation and analysis was launched by PerkinElmer, Inc. and Honeycomb Biotechnologies, Inc. This is a portable device used by the HIVE solution to capture, store, and prepare RNA-Seq libraries for several cell types, including fragile and labile cells such as granulocytes, nephrons, hepatocytes, and neurons.
- In 2021, CytoFlex SRT Benchtop Cell Sorter from Beckman Coulter Life Sciences was launched, which includes extended laser and color options for use in labs of all sizes. With the initiation of new technology, automating, streamlining, and stream maintenance became easy.
Global Single Cell Genomics and Proteomics Market Scope
The single cell genomics and proteomics market is segmented on the basis of single cell genomics process step, single cell genomics analytical technology, proteomics components, proteomics reagents, proteomics services & software, single cell genomics applications, proteomic application and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Single Cell Genomics Process Step
- Cell isolation
- Sample Preparation
- Genomics Analysis
Single Cell Genomics Analytical Technology
- Tubing PCR
- Qpcr
- Microarray
- Next-Generation-Sequencing
- Other
Proteomics Components
- Instruments
- Reagents
- Services
Proteomics Reagents
- Immunoassay Reagents
- Spectroscopy Reagents
- Chromatography Reagents
- Protein Microarray Reagents
- X-Ray Crystallography Reagents
- Electrophoresis Reagents
- Protein Fractionation Reagents
Proteomics Services & Software
- Core Proteomics Services
- Bioinformatics Software & Services
Single Cell Genomics Applications
- Genomic Variation
- Subpopulation Characterization
- Circulating Tumor Cells
- Cell Differentiation / Reprograming Method
- Others
Proteomic Application
- Drug Discovery
- Disease Diagnosis
- Other
End- Users
- Academic Institutes
- Biopharmaceutical Companies
- Clinical Research Institutes
Single Cell Genomics and Proteomics Market Regional Analysis/Insights
The single cell genomics and proteomics market is analyzed and market size insights and trends are provided by single cell genomics process step, single cell genomics analytical technology, proteomics components, proteomics reagents, proteomics services & software, single cell genomics applications, proteomic application and end-users as referenced above.
The countries covered in the single cell genomics and proteomics market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the single cell genomics and proteomics market due to multiple government funding programs, increasing awareness regarding personal healthcare and associated expenditure, high adoption of novel analytical tools and techniques, and the wide availability of trained personnel. Also, the U.S. is a major contributor to industry growth in the North American region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period because of the presence of national centers and local emerging economies offering such facilities. Furthermore, the major market players associated with this market are also enhancing the growth of the market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The single cell genomics and proteomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for single cell genomics and proteomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the single cell genomics and proteomics market. The data is available for historic period 2011-2021.
Competitive Landscape and Single Cell Genomics and Proteomics Market Share Analysis
The single cell genomics and proteomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to single cell genomics and proteomics market.
Some of the major players operating in the single cell genomics and proteomics market are:
- Thermo Fisher Scientific (U.S.)
- QIAGEN (Netherlands)
- Agilent Technologies, Inc. (U.S.)
- McKesson Corporation (U.S)
- R1 RCM Inc., (U.S)
- Allscripts Healthcare, LLC, (U.S)
- Accenture, (Ireland)
- Siemens, (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bio-Rad Laboratories, Inc. (U.S.)
- BGI (China)
- B.D. (U.S.)
- Danaher (U.S.)
- Bruker (U.S.)
- 10x Genomics (U.S.)
- Luminex Corporation. (U.S.)
- Promega Corporation (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
